Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-07-24

Clinical Trial Update: Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial update investigates whether IL-28B polymorphisms rs12979860 and rs4803217 influence miRNA deregulation in hepatitis C–related hepatocellular ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dr.Waleed Samir | Conditions: HCV Infection ( Genotype 4) | NA | Status: UNKNOWN